Literature DB >> 29155679

Antidepressant Use Among Persons Aged 12 and Over:United States,2011-2014.

Laura A Pratt, Debra J Brody, Qiuping Gu.   

Abstract

Antidepressants are one of the three most commonly used therapeutic drug classes in the United States (1). While the majority of antidepressants are taken to treat depression, antidepressants can also be taken to treat other conditions, like anxiety disorders. This Data Brief provides the most recent estimates of antidepressant use in the U.S. noninstitutionalized population, including prevalence of use by age, sex, race and Hispanic origin, and length of use. This report also describes trends in the prevalence of antidepressant use from 1999–2002 to 2011–2014. All material appearing in this report is in the public domain and may be reproduced or copied without permission; citation as to source, however, is appreciated.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29155679

Source DB:  PubMed          Journal:  NCHS Data Brief        ISSN: 1941-4935


  62 in total

1.  Mood matters: a national survey on attitudes to depression.

Authors:  John R Kelly; Mary Cosgrove; Cian Judd; Kathy Scott; Aoibheann Mc Loughlin; Veronica O'Keane
Journal:  Ir J Med Sci       Date:  2019-04-02       Impact factor: 1.568

Review 2.  Evaluating the risk of QTc prolongation associated with antidepressant use in older adults: a review of the evidence.

Authors:  Matthew P Rochester; Allison M Kane; Sunny Anne Linnebur; Danielle R Fixen
Journal:  Ther Adv Drug Saf       Date:  2018-05-04

3.  Selective Serotonin Reuptake Inhibitors Reduce Longitudinal Growth in Risperidone-Treated Boys.

Authors:  Chadi A Calarge; James A Mills; Lefkothea Karaviti; Antonio L Teixeira; Babette S Zemel; Jose M Garcia
Journal:  J Pediatr       Date:  2018-06-27       Impact factor: 4.406

4.  Major Depression and Subthreshold Depression among Older Adults Receiving Home Care.

Authors:  Xiaoling Xiang; Amanda Leggett; Joseph A Himle; Helen C Kales
Journal:  Am J Geriatr Psychiatry       Date:  2018-05-08       Impact factor: 4.105

5.  Degree of serotonin reuptake inhibition of antidepressants and ischemic risk: A cohort study.

Authors:  Antonios Douros; Sophie Dell'Aniello; Golsa Dehghan; Jean-François Boivin; Christel Renoux
Journal:  Neurology       Date:  2019-08-07       Impact factor: 9.910

6.  Antidepressant use in patients with heart failure.

Authors:  Kenneth E Freedland; Brian C Steinmeyer; Robert M Carney; Judith A Skala; Michael W Rich
Journal:  Gen Hosp Psychiatry       Date:  2020-04-25       Impact factor: 3.238

7.  Urinary selective serotonin reuptake inhibitors across critical windows of pregnancy establishment: a prospective cohort study of fecundability and pregnancy loss.

Authors:  Lindsey A Sjaarda; Jeannie G Radoc; Kerry S Flannagan; Sunni L Mumford; Keewan Kim; Neil J Perkins; Robert M Silver; Enrique F Schisterman
Journal:  Fertil Steril       Date:  2020-10-14       Impact factor: 7.329

8.  Gaps in the Management of Depression Symptoms Following Cancer Diagnosis: A Population-Based Analysis of Prospective Patient-Reported Outcomes.

Authors:  Julie Hallet; Laura E Davis; Elie Isenberg-Grzeda; Alyson L Mahar; Haoyu Zhao; Victoria Zuk; Lesley Moody; Natalie G Coburn
Journal:  Oncologist       Date:  2020-02-26

9.  Long-term Association of Depression Symptoms and Antidepressant Medication Use With Incident Cardiovascular Events in the Look AHEAD (Action for Health in Diabetes) Clinical Trial of Weight Loss in Type 2 Diabetes.

Authors:  Helen P Hazuda; Sarah A Gaussoin; Rena R Wing; Susan Z Yanovski; Karen C Johnson; Mace Coday; Thomas A Wadden; Edward S Horton; Brent Van Dorsten; William C Knowler
Journal:  Diabetes Care       Date:  2019-03-04       Impact factor: 19.112

10.  Small Molecule Antipsychotic Aripiprazole Potentiates Ozone-Induced Inflammation in Airway Epithelium.

Authors:  Adam M Speen; Jessica R Hoffman; Hye-Young H Kim; Yael N Escobar; Grace E Nipp; Meghan E Rebuli; Ned A Porter; Ilona Jaspers
Journal:  Chem Res Toxicol       Date:  2019-09-11       Impact factor: 3.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.